Champions Oncology (CSBR) Net Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 5.69% |
| Apr 30, 2026 | 3.84% |
| Jan 31, 2026 | -4.32% |
| Oct 31, 2025 | -25.58% |
| Jul 31, 2025 | 19.00% |
| Apr 30, 2025 | 5.40% |
| Jan 31, 2025 | -2.09% |
| Oct 31, 2024 | -17.47% |
| Jul 31, 2024 | 17.76% |
| Apr 30, 2024 | -90.88% |
| Jan 31, 2024 | -22.62% |
| Oct 31, 2023 | -4.00% |
| Jul 31, 2023 | -103.39% |
| Apr 30, 2023 | -49.28% |
| Jan 31, 2023 | 15.30% |
| Oct 31, 2022 | 64.47% |
| Jul 31, 2022 | 19.83% |
| Apr 30, 2022 | 29.10% |
| Jan 31, 2022 | 46.12% |
| Oct 31, 2021 | 51.84% |